Quidel Corp. completed the $680 million acquisition of Alere's Triage MeterPro cardiovascular and toxicology business, as well as the B-type Naturietic Peptide assay business.
The purchase price included $400 million in cash for the Triage business and a $280 million in deferred consideration for the assay business.
The Triage assets also include the facilities in San Diego.